학술논문
Impact of Baseline Characteristics on the Efficacy and Safety of Eptinezumab in Patients With Migraine: Subgroup Analyses of PROMISE-1 and PROMISE-2
Document Type
Article
Author
Source
In: Clinical Therapeutics . (Clinical Therapeutics, March 2022, 44(3):389-402)
Subject
Language
English
ISSN
1879114X
01492918
01492918